Product Image

Ginkgo Biloba 120 mg

Protocol For Life Balance
4.8
★ ★ ★ ★ ★
(226 ratings)
Ginkgo
Eleuthero 250 mg
Product Image
Score76
A practical ginkgo dose with a modest eleuthero addition, held back by missing marker percentages and purity details.
How scoring works
Quantity:100 Capsule(s) • (100 servings)
Goals:
Mental Focus
Cognitive Support
Brain Health
Productivity Boost

Score 76

A practical ginkgo dose with a modest eleuthero addition, held back by missing marker percentages and purity details.
How scoring works
$23.00($0.23 per serving)
Pure Formulas
$ 23.00
Amazon
$ 23.00
iHerb
$ 23.00
Report prices

Analysis

Ginkgo supplies the clearest cognitive rationale through cerebral circulation, while eleuthero may contribute mild stamina during stress. The pairing is more relevant to focus and cognitive support than to broad brain nutrition or vision support.

Both flavonglycosides and terpene lactones are named, but the label does not show their percentages or a ginkgolic-acid purity limit. Eleuthero is listed at 250 mg without a plant part, extract ratio, or active-marker standardization.

The formula makes sense for adults seeking a once-daily botanical approach without caffeine. Results are less predictable than with fully standardized extracts, and ginkgo interactions make medication and surgery context important.

Who is it for
  • Adults seeking non-stimulant cognitive support
  • People interested in circulation and stress-resilience botanicals
Best for
  • Cognitive support with a circulation focus
  • Mental stamina without added caffeine

Pros

  • Provides 120 mg of ginkgo extract
  • Names both major ginkgo marker groups
  • Adds 250 mg of organic eleuthero
  • Offers a long supply per bottle

Cons

  • Ginkgo marker percentages are not provided
  • No ginkgolic-acid limit is stated
  • Eleuthero is modest and unstandardized
  • Vision-support coverage is narrow

Warnings

  • Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines and around surgery.
  • Eleuthero may affect blood pressure or sensitivity to stimulant medicines in susceptible users.

Nutrient quality

78 High impact

The ginkgo amount is practical and the marker groups are identified. Missing marker percentages, purity limits, and eleuthero standardization reduce confidence in quality.

.

Ingredient transparency

76 High impact

Both botanical amounts are disclosed without a hidden blend. Intake directions, inactive ingredients, and important extract details are not supplied.

.

Customer satisfaction

66 High impact

The supplied average rating is strong and comes from a limited rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.

.

Value for money

82 Highest impact

A practical ginkgo amount and focused formula offer good value at a modest serving cost. Missing extract percentages keep quality assurance incomplete.

.
Report analysis

Goals

Mental Focus
Mental Focus
Impact
High effect
B- Goal FitB+ Strength of SupportB- CoverageA Formula Quality

Ginkgo may support processing speed and attention through cerebral circulation, while eleuthero adds stress and fatigue resilience. The pairing offers complementary coverage without relying on a stimulant.

The ginkgo amount is substantial and active marker names are provided, though their percentages are unclear in the supplied label data. Ginkgo can increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Eleuthero Disputed 3 studies
Ginkgo Supportive 28 studies
Cognitive Support
Cognitive Support
Impact
High effect
B+ Goal FitB- Strength of SupportB- CoverageA- Formula Quality

Ginkgo directly supports cerebral circulation, while eleuthero may add resilience to fatigue. The ginkgo amount reaches a commonly used daily level.

Active-marker percentages and a ginkgolic-acid limit are not supplied, and the eleuthero amount is modest and unstandardized. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Eleuthero No effect 1 study
Ginkgo Supportive 87 studies
Brain Health
Brain Health
Impact
High effect
B- Goal FitC+ Strength of SupportC- CoverageB Formula Quality

Ginkgo targets cerebral circulation and may support cognitive performance in selected settings. Evidence is mixed across populations, and the added eleuthero does not turn it into broad neurological support.

The ginkgo amount matches a practical daily target, but active-marker percentages and a ginkgolic acid limit are missing. Ginkgo may increase bleeding risk for users taking anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Productivity Boost
Productivity Boost
Impact
High effect
B- Goal FitC Strength of SupportC CoverageB+ Formula Quality
Eleuthero · 250 mgEleuthero · 250 mg

Ginkgo may support processing and memory through cerebral circulation, while eleuthero may help stress-related stamina. The ginkgo amount is appropriate, but active-marker percentages are not disclosed.

Eleuthero is unstandardized and appears underdosed, limiting the adaptogenic contribution. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Eleuthero No effect 1 study
Eleuthero Not classified

No linked studies yet.

Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Vision Support
Vision Support
Impact
Moderate effect
D+ Goal FitB+ Strength of SupportD- CoverageC- Formula Quality

Ginkgo may support ocular microcirculation in specific vascular situations, but it is not a foundational vision nutrient. The product lacks carotenoids, antioxidant vitamins, zinc, and DHA.

The extract amount is appropriate and both key marker groups are named, yet their percentages and a ginkgolic acid limit are missing. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines, while eleuthero adds little direct ocular value.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
Ginkgo extract (Ginkgoflavonglycosides, Terpene Lactones)
 120 mg
organic Eleuthero
250 mg
Gluten Free Adults 18–50 Vegan Dairy Free Vegetarian
Report overview
Ginkgo (Ginkgoflavonglycosides, Terpene Lactones) · 120 mg OverallScore66
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

The daily serving provides 120 mg of ginkgo extract and clearly names both key active-marker groups. Their percentages and a ginkgolic acid limit are not supplied, which leaves extract quality incompletely verified. The aligned dose, full amount disclosure, and low cost make it a practical option despite that uncertainty.

View ingredientView products
Eleuthero · 250 mg OverallScore29
F Active Ingredient Quality & BioavailabilityD+ Dose, Safety & Label TransparencyF Value

Eleuthero is clearly measured but underdosed as an unstandardized ingredient with no plant-part detail. Ginkgo is the dominant standardized botanical, so the formula fits ginkgo use better than effective Eleuthero supplementation. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

View ingredientView products
Loading alternative details
83 Performance

Ginkgold 120 mg

Nature's Way
<p>It offers a stronger ingredient-quality case because 120 mg of branded Ginkgold provides a well-standardized ginkgo extract with strong purity disclosure. Compared with Ginkgo Biloba 120 mg, it omits eleuthero, and ginkgo may add to bleeding risk with anticoagulant or antiplatelet medicines.</p>
84 Performance

Ginkgo Biloba Phytosome 60 mg

Natural Factors HerbalFactors
<p>It offers a stronger ingredient-quality case because 60 mg of recognized GinkgoSelect phytosome provides enhanced-delivery ginkgo in a focused formula. Compared with Ginkgo Biloba 120 mg, the smaller amount is designed around phytosome delivery, although the supplied facts do not state every active-marker percentage.</p>
79 Performance

Dual Ginseng Plus

Swanson Superior Herbs
<p>It offers a stronger ingredient-quality case because 200 mg of eleuthero extract is paired with standardized American and Korean ginseng plus ashwagandha. Compared with Ginkgo Biloba 120 mg, it omits ginkgo, so it better matches the adaptogen side of the original than its direct ginkgo component.</p>
84 Budget

Ginkgo Biloba Certified Extract 120 mg

Life Extension
<p>It lowers the recurring cost while 120 mg of ginkgo names both key marker groups and states a very low ginkgolic-acid limit. Compared with Ginkgo Biloba 120 mg, it omits eleuthero, and ginkgo may add to bleeding risk with anticoagulant or antiplatelet medicines.</p>
83 Budget

Ginkgo Biloba 60 mg

Swanson Superior Herbs
<p>It lowers the recurring cost while 60 mg of GinkgoSelect supplies a standardized maintenance-level ginkgo extract. Compared with Ginkgo Biloba 120 mg, the amount is lower than the original’s 120 mg or larger ginkgo serving, and ginkgo may add to bleeding risk with anticoagulant or antiplatelet medicines.</p>
84 Budget

Ginkgo Biloba 120 mg

Nature's Bounty
<p>It lowers the recurring cost while 120 mg of ginkgo names both flavone glycosides and terpene lactones in a simple formula. Compared with Ginkgo Biloba 120 mg, marker percentages and a purity limit are missing, and the formula omits eleuthero.</p>
81 Value

Extra Strength Ginkgo 120 mg

Doctor's Best
<p>It balances formulation quality and cost because 120 mg of ginkgo extract names both flavonol glycosides and terpene lactones. Compared with Ginkgo Biloba 120 mg, marker percentages and a purity limit are incomplete, and ginkgo may add to bleeding risk with relevant medicines.</p>
81 Value

Eleuthero Glycerite

Herb Pharm
<p>It balances formulation quality and cost because 817 mg of clearly identified eleuthero root extract provides a focused alcohol-free adaptogen option. Compared with Ginkgo Biloba 120 mg, it omits ginkgo and does not state an extract ratio or eleutheroside percentage.</p>
84 Value

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
<p>It balances formulation quality and cost because 120 mg of ginkgo names both flavone glycosides and terpene lactones at a practical recurring cost. Compared with Ginkgo Biloba 120 mg, marker percentages and a purity guarantee are absent, and the formula does not include eleuthero.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health Cognitive Support forGinkgo
  2. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  3. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support forGinkgo
  4. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P · Journal of clinical epidemiology · 2003
    Randomized trial214 participantsBrain Health forGinkgo
  5. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  6. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Cognitive Support Productivity Boost forGinkgo
  7. Ginkgo biloba extract EGb 761 in patients with dementia and a history of cerebral infarction-meta-analysis of pooled data from randomised clinical trials.
    Feng JX; Zheng MQ; Tian X; Zimmermann A; Wang AX; Meng X · Frontiers in neurology · 2026
    Meta-analysis488 participants4 studies pooledBrain Health forGinkgo
  8. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  9. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults.
    Burns NR; Bryan J; Nettelbeck T · Human psychopharmacology · 2006
    Randomized trial197 participantsMental Focus forGinkgo
  10. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  11. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsMental Focus Productivity Boost forGinkgo
  12. Complementary medicines (herbal and nutritional products) in the treatment of Attention Deficit Hyperactivity Disorder (ADHD): a systematic review of the evidence.
    Sarris J; Kean J; Schweitzer I; Lake J · Complementary therapies in medicine · 2012
    Systematic review16 studies pooledMental Focus forGinkgo
  13. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  14. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  15. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  16. Ginkgo biloba--an appraisal.
    Dubey AK; Shankar PR; Upadhyaya D; Deshpande VY · Kathmandu University medical journal (KUMJ) · 2007
    Narrative reviewVision Support forGinkgo
  17. Ginkgo biloba extract for age-related macular degeneration.
    Evans JR · The Cochrane database of systematic reviews · 2013
    Systematic review119 participants2 studies pooledVision Support forGinkgo
  18. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  19. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  20. No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study.
    Schaffler K; Wolf OT; Burkart M · Pharmacopsychiatry · 2014
    Randomized trial144 participantsCognitive Support Mental Focus Productivity Boost forEleuthero
  21. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  22. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  23. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  24. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  25. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity.
    Panossian A; Wikman G · Current clinical pharmacology · 2009
    Narrative reviewMental Focus forEleuthero
  26. Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration.
    Panossian A; Wagner H · Phytotherapy research : PTR · 2005
    Narrative reviewMental Focus forEleuthero
  27. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  28. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  29. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  30. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  31. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  32. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  33. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  34. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  35. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  36. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  37. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo